Filtros : "Universidade Federal do Rio de Janeiro (UFRJ)" "Abdalla, Dulcinéia Saes Parra" Removidos: "FCFGRU999" "FM-MOG" "DONADELLI, MARISÍLVIA" "Grécia" "bf" "1958" "Tese (Doutorado)" "SBF" "Enfermagem em Saúde Pública" " GRU999QBQ" "ECONOMIA, ADMINISTRACAO E SOCIOLOGIA" "ENGENHARIA DE COMP E SIST DIGITAIS" "Hirata, Mario Hiroyuki" "FCF-FBA" "Revista Brasileira de Enfermagem" Limpar

Filtros



Refine with date range


  • Source: CardioRenal Medicine. Unidade: FCF

    Subjects: ACIDOSE, NEFROPATIAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIZZETTO, Federica et al. One-year conservative care using sodium bicarbonate supplementation is associated with a decrease in electronegative LDL in chronic kidney disease patients: a pilot study. CardioRenal Medicine, v. 7, n. 4, p. 334-341, 2017Tradução . . Disponível em: https://doi.org/10.1159/000478733. Acesso em: 15 jul. 2024.
    • APA

      Rizzetto, F., Mafra, D., Barra, A. B., Melo, G. P. de, Abdalla, D. S. P., & Leite Junior, M. (2017). One-year conservative care using sodium bicarbonate supplementation is associated with a decrease in electronegative LDL in chronic kidney disease patients: a pilot study. CardioRenal Medicine, 7( 4), 334-341. doi:10.1159/000478733.
    • NLM

      Rizzetto F, Mafra D, Barra AB, Melo GP de, Abdalla DSP, Leite Junior M. One-year conservative care using sodium bicarbonate supplementation is associated with a decrease in electronegative LDL in chronic kidney disease patients: a pilot study [Internet]. CardioRenal Medicine. 2017 ; 7( 4): 334-341.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1159/000478733.
    • Vancouver

      Rizzetto F, Mafra D, Barra AB, Melo GP de, Abdalla DSP, Leite Junior M. One-year conservative care using sodium bicarbonate supplementation is associated with a decrease in electronegative LDL in chronic kidney disease patients: a pilot study [Internet]. CardioRenal Medicine. 2017 ; 7( 4): 334-341.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1159/000478733.
  • Source: Renal Failure. Unidade: FCF

    Subjects: ZINCO, HEMODIÁLISE, ARTERIOSCLEROSE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOBO, Julie Calixto et al. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality. Renal Failure, v. 35, n. 5, p. 680-685, 2013Tradução . . Disponível em: https://doi.org/10.3109/0886022X.2013.789960. Acesso em: 15 jul. 2024.
    • APA

      Lobo, J. C., Stockler Pinto, M. B., Farage, N. E., Faulin, T. do E. S., Abdalla, D. S. P., Torres, J. P. M., et al. (2013). Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality. Renal Failure, 35( 5), 680-685. doi:10.3109/0886022X.2013.789960
    • NLM

      Lobo JC, Stockler Pinto MB, Farage NE, Faulin T do ES, Abdalla DSP, Torres JPM, Velarde LGC, Mafra D. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality [Internet]. Renal Failure. 2013 ; 35( 5): 680-685.[citado 2024 jul. 15 ] Available from: https://doi.org/10.3109/0886022X.2013.789960
    • Vancouver

      Lobo JC, Stockler Pinto MB, Farage NE, Faulin T do ES, Abdalla DSP, Torres JPM, Velarde LGC, Mafra D. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality [Internet]. Renal Failure. 2013 ; 35( 5): 680-685.[citado 2024 jul. 15 ] Available from: https://doi.org/10.3109/0886022X.2013.789960
  • Source: Clinica Chimica Acta. Unidade: FCF

    Subjects: ARTERIOSCLEROSE, HEMODIÁLISE, INFLAMAÇÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEAL, Viviane O et al. Is zinc-α2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis?. Clinica Chimica Acta, v. 413, n. 5-6, p. 616-619, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2011.12.002. Acesso em: 15 jul. 2024.
    • APA

      Leal, V. O., Lobo, J. C., Stockler Pinto, M. B., Farage, N. E., Abdalla, D. S. P., Leite Junior, M., & Mafra, D. (2012). Is zinc-α2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis? Clinica Chimica Acta, 413( 5-6), 616-619. doi:10.1016/j.cca.2011.12.002
    • NLM

      Leal VO, Lobo JC, Stockler Pinto MB, Farage NE, Abdalla DSP, Leite Junior M, Mafra D. Is zinc-α2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis? [Internet]. Clinica Chimica Acta. 2012 ; 413( 5-6): 616-619.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.cca.2011.12.002
    • Vancouver

      Leal VO, Lobo JC, Stockler Pinto MB, Farage NE, Abdalla DSP, Leite Junior M, Mafra D. Is zinc-α2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis? [Internet]. Clinica Chimica Acta. 2012 ; 413( 5-6): 616-619.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.cca.2011.12.002
  • Source: Journal of Renal Nutrition. Unidade: FCF

    Subjects: LIPOPROTEÍNAS LDL, HEMODIÁLISE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOBO, Julie Calixto et al. Association between circulating electronegative low-density lipoproteins and serum ferritin in hemodialysis patients: A pilot study. Journal of Renal Nutrition, v. 22, n. 3, p. 350-356, 2012Tradução . . Disponível em: https://doi.org/10.1053/j.jrn.2011.05.002. Acesso em: 15 jul. 2024.
    • APA

      Lobo, J. C., Farage, N. E., Abdalla, D. S. P., Velarde, L. G. C., Torres, J. P. M., & Mafra, D. (2012). Association between circulating electronegative low-density lipoproteins and serum ferritin in hemodialysis patients: A pilot study. Journal of Renal Nutrition, 22( 3), 350-356. doi:10.1053/j.jrn.2011.05.002
    • NLM

      Lobo JC, Farage NE, Abdalla DSP, Velarde LGC, Torres JPM, Mafra D. Association between circulating electronegative low-density lipoproteins and serum ferritin in hemodialysis patients: A pilot study [Internet]. Journal of Renal Nutrition. 2012 ; 22( 3): 350-356.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1053/j.jrn.2011.05.002
    • Vancouver

      Lobo JC, Farage NE, Abdalla DSP, Velarde LGC, Torres JPM, Mafra D. Association between circulating electronegative low-density lipoproteins and serum ferritin in hemodialysis patients: A pilot study [Internet]. Journal of Renal Nutrition. 2012 ; 22( 3): 350-356.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1053/j.jrn.2011.05.002
  • Source: Clinica Chimica Acta. Unidade: FCF

    Subjects: LIPOPROTEÍNAS LDL, INFLAMAÇÃO, HEMODIÁLISE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOBO, Julie Calixto et al. Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients. Clinica Chimica Acta, v. 412, n. 19-20, p. 1788-1792, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2011.05.034. Acesso em: 15 jul. 2024.
    • APA

      Lobo, J. C., Mafra, D., Farage, N. E., Faulin, T. do E. S., Abdalla, D. S. P., Nobrega, A. C. L. da, & Torres, J. P. M. (2011). Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients. Clinica Chimica Acta, 412( 19-20), 1788-1792. doi:10.1016/j.cca.2011.05.034
    • NLM

      Lobo JC, Mafra D, Farage NE, Faulin T do ES, Abdalla DSP, Nobrega ACL da, Torres JPM. Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients [Internet]. Clinica Chimica Acta. 2011 ; 412( 19-20): 1788-1792.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.cca.2011.05.034
    • Vancouver

      Lobo JC, Mafra D, Farage NE, Faulin T do ES, Abdalla DSP, Nobrega ACL da, Torres JPM. Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients [Internet]. Clinica Chimica Acta. 2011 ; 412( 19-20): 1788-1792.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.cca.2011.05.034
  • Source: Nephron Clinical Practice. Unidade: FCF

    Subjects: LIPOPROTEÍNAS LDL, HEMODIÁLISE, DOENÇAS CARDIOVASCULARES

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOBO, Julie Calixto et al. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Nephron Clinical Practice, v. 108, n. 4, p. c298-c304, 2008Tradução . . Disponível em: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=127982&Ausgabe=236423&ProduktNr=228539&filename=127982.pdf. Acesso em: 15 jul. 2024.
    • APA

      Lobo, J. C., Santos, F., Grosso, D. de M., Lima, F., Barreira, A. F., Mafra, D., & Abdalla, D. S. P. (2008). Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Nephron Clinical Practice, 108( 4), c298-c304. Recuperado de http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=127982&Ausgabe=236423&ProduktNr=228539&filename=127982.pdf
    • NLM

      Lobo JC, Santos F, Grosso D de M, Lima F, Barreira AF, Mafra D, Abdalla DSP. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis [Internet]. Nephron Clinical Practice. 2008 ; 108( 4): c298-c304.[citado 2024 jul. 15 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=127982&Ausgabe=236423&ProduktNr=228539&filename=127982.pdf
    • Vancouver

      Lobo JC, Santos F, Grosso D de M, Lima F, Barreira AF, Mafra D, Abdalla DSP. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis [Internet]. Nephron Clinical Practice. 2008 ; 108( 4): c298-c304.[citado 2024 jul. 15 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=127982&Ausgabe=236423&ProduktNr=228539&filename=127982.pdf
  • Source: Insect Biochemistry and Molecular Biology. Unidade: FCF

    Subjects: ANTIOXIDANTES, LIPOPROTEÍNAS, BIOQUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MAYA-MONTEIRO, Clarissa Menezes et al. HeLp, a heme-transporting lipoprotein with an antioxidant role. Insect Biochemistry and Molecular Biology, v. 34, n. 1, p. 81-87, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ibmb.2003.09.005. Acesso em: 15 jul. 2024.
    • APA

      Maya-Monteiro, C. M., Alves, L. R., Pinhal, N., Abdalla, D. S. P., & Oliveira, P. L. de. (2004). HeLp, a heme-transporting lipoprotein with an antioxidant role. Insect Biochemistry and Molecular Biology, 34( 1), 81-87. doi:10.1016/j.ibmb.2003.09.005
    • NLM

      Maya-Monteiro CM, Alves LR, Pinhal N, Abdalla DSP, Oliveira PL de. HeLp, a heme-transporting lipoprotein with an antioxidant role [Internet]. Insect Biochemistry and Molecular Biology. 2004 ; 34( 1): 81-87.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.ibmb.2003.09.005
    • Vancouver

      Maya-Monteiro CM, Alves LR, Pinhal N, Abdalla DSP, Oliveira PL de. HeLp, a heme-transporting lipoprotein with an antioxidant role [Internet]. Insect Biochemistry and Molecular Biology. 2004 ; 34( 1): 81-87.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.ibmb.2003.09.005

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024